Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections

Rheumatology

Volumn 49, Issue 7, 2010, Pages 1346-1353

  Kimoto, Yasutaka ^a   Horiuchi, Takahiko ^a   Tsukamoto, Hiroshi ^a   Kiyohara, Chikako ^a   Mitoma, Hiroki ^a   Uchino, Ayumi ^a   Furugo, Isao ^b   Yoshizawa, Seiji ^c   Ueda, Akira ^d   Harashima, Shinichi ^e   Sawabe, Takuya ^f   Tahira, Tomoko ^g   Hayashi, Kenshi ^g   Yoshizawa, Shigeru ^h   Shimoda, Terufumi ^h   Akashi, Koichi ^a   Harada, Mine ⁱ  

^a KYUSHU UNIVERSITY   (Japan)

^b JR Kyushu Hospital   (Japan)

^c HAMANOMACHI HOSPITAL   (Japan)

^d MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^g KYUSHU UNIVERSITY   (Japan)

^h FUKUOKA NATIONAL HOSPITAL   (Japan)

ⁱ Omuta National Hospital   (Japan)

Author keywords

Genetic analysis; Infection; Killer cell immunoglobulin like receptor; Systemic lupus erythematosus

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DNA; IMMUNOSUPPRESSIVE AGENT; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS5; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; METHYLPREDNISOLONE; UNCLASSIFIED DRUG;

ABDOMINAL ABSCESS; ARTICLE; ASEPTIC MENINGITIS; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; CASE CONTROL STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG PULSE THERAPY; EMPYEMA; ENCEPHALITIS; GENE LOCUS; GENETIC IDENTIFICATION; HERPES ZOSTER; HUMAN; INFECTION; INFECTION RISK; JAPANESE; LUNG ASPERGILLOSIS; LUNG DISEASE; LUNG SUPPURATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MONONUCLEOSIS; MYCOSIS; NOCARDIOSIS; PREVALENCE; PRIORITY JOURNAL; PULMONARY CRYPTOCOCCOSIS; RHABDOMYOLYSIS; SEPSIS; STREPTOCOCCUS PNEUMONIA; SYSTEMIC LUPUS ERYTHEMATOSUS; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, GENETIC; RECEPTORS, KIR2DL5; REGRESSION ANALYSIS;

EID: 77954188305     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq050     Document Type: Article

References (44)

1. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005;5: 201-14.
2. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995;3:801-9.
3. Vitale M, Sivori S, Pende D et al. Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. Proc Natl Acad Sci USA 1996;93:1453-7.
4. Martin MP, Gao X, Lee JH et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002;31:429-34.
5. Khakoo SI, Thio CL, Martin MP et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004;305:872-4.
6. Magilavy DB, Steinberg AD, Latta SL. High hepatic natural killer cell activity in murine lupus. J Exp Med 1987;166: 271-6.
7. Nilsson N, Carlsten H. Enhanced natural but diminished antibody-mediated cytotoxicity in the lungs of MRL lpr/lpr mice. Clin Exp Immunol 1996;105:480-5.
8. Yen JH, Moore BE, Nakajima T et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001;193: 1159-67.
9. Momot T, Koch S, Hunzelmann N et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 2004;50:1561-5.
10. Miyashita R, Tsuchiya N, Yabe T et al. Association of killer cell immunoglobulin-like receptor genotypes with microscopic polyangiitis. Arthritis Rheum 2006;54:992-7.
11. Suzuki Y, Hamamoto Y, Ogasawara Y et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol 2004;122:1133-6.
12. Wong M, Tsao BP. Current topics in human SLE genetics. Springer Semin Immunopathol 2006;28:97-107.
13. Miyagawa H, Yamai M, Sakaguchi D et al. Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology 2008;47:158-64.
14. Koyama T, Tsukamoto H, Masumoto K et al. A novel polymorphism of the human APRIL gene is associated with systemic lupus erythematosus. Rheumatology 2003; 42:980-5.
15. Tao K, Fujii M, Tsukumo S et al. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis 2007;66:905-9.
16. Horiuchi T, Kiyohara C, Tsukamoto H et al. A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis. Ann Rheum Dis 2007;66:320-4.
17. Liossis SN, Ding XZ, Dennis GJ, Tsokos GC. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain. J Clin Invest 1998;101: 1448-57.
18. Mitoma H, Horiuchi T, Kimoto Y et al. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus. Int J Mol Med 2005;16:609-15.
19. Tamimoto Y, Horiuchi T, Tsukamoto H et al. A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans syndrome: immunological analysis of B cells, T cells and cytokines. Rheumatology 2008;47:821-7.
20. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
21. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40:1725.
22. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
23. Horiuchi T, Gondo H, Miyagawa H et al. Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT. Genes Immun 2005;6:162-6.
24. Gomez-Lozano N, Vilches C. Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue antigens 2002;59:184-93.
25. Martin MP, Nelson G, Lee JH et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 2002;169:2818-22.
26. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 2003;52:2639-42.
27. Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity 2005;38:473-85.
28. Alarcon GS. Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Infect Dis Clin North Am 2006;20:849-75.
29. Vilches C, Rajalingam R, Uhrberg M, Gardiner CM, Young NT, Parham P. KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains. J Immunol 2000;164:5797-804.
30. Estefania E, Flores R, Gomez-Lozano N, Aguilar H, Lopez-Botet M, Vilches C. Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. J Immunol 2007;178:4402-10.
31. Yusa S, Catina TL, Campbell KS. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2). J Immunol 2004;172:7385-92.
32. Snyder MR, Nakajima T, Leibson PJ, Weyand CM, Goronzy JJ. Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-independent mechanisms. J Immunol 2004;173: 3725-31.
33. Pellett F, Siannis F, Vukin I, Lee P, Urowitz MB, Gladman DD. KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens 2007;69(Suppl. 1):106-8.
34. Shi FD, Van Kaer L. Reciprocal regulation between natural killer cells and autoreactive T cells. Nat Rev Immunol 2006;6:751-60.
35. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, Lanier LL. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol 2004;173:3716-24.
36. Liu R, Van Kaer L, La Cava A et al. Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J Immunol 2006;176:5247-54.
37. van Bergen J, Thompson A, van der Slik A, Ottenhoff TH, Gussekloo J, Koning F. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol 2004;173:6719-26.
38. Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7-CD28-T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97: 2027-37.
39. Namekawa T, Snyder MR, Yen JH et al. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 2000;165: 1138-45.
40. Segal S, Hill AV. Genetic susceptibility to infectious disease. Trends Microbiol 2003;11:445-8.
41. Garred P, Madsen HO, Halberg P et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 1999;42: 2145-52.
42. Bultink IE, Hamann D, Seelen MA et al. Deficiency of functional mannose-binding lectin is not associated with infections in patients with systemic lupus erythematosus. Arthritis Res Ther 2006;8:R183.
43. Mok MY, Ip WK, Lau CS, Lo Y, Wong WH, Lau YL. Mannose-binding lectin and susceptibility to infection in Chinese patients with systemic lupus erythematosus. J Rheumatol 2007;34:1270-6.
44. Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2001;2:442-50.